Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Brachytherapy × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 12 Neoplasms 4 Breast Neoplasms 3 Vaginal Neoplasms 2 Uterine Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vulvar Neoplasms 1 Stage IA Uterine Sarcoma 1 Radiation Injuries 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡